Post Issuance Amendment of Allowed Claims

Israel Patent No. 122910 to Genentech is directed to a stable isotonic lyophilized protein formulation.

On allowance of the Application under section 17c, Perrigo and Celltrion filed for the mark to be cancelled.

Patentee requested to amend the claims under Section 65 and 66. The Patent Office has decided that the issue of amending claims post allowance requires clarification globally, and the patent and cancellation proceeding are suspended pending a Circular on the matter from the Commissioner of Patents.


Post allowance amendments when a patent is undergoing a cancellation proceeding is indeed something that should be considered globally. With a pending case, it is not clear that this can happen without consideration of the specific case. The Applicant is represented by the alma mater of the commissioner, which doesn’t help things. We suspect that whatever is decided, the case will be appealed to the courts.

Categories: Israel Patent, Israel Patent Agency, Israel Patent Office Rulings, החלטת רשות הפטנטים, פטנט, פטנטים

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: